DVA Chart

1 Month

	Date	Diff
	2023-03-20	+1.59 %
Healthcare services company, Modivcare, has announced the appointment of Anne Bailey as President of its Home division, which includes personal care services, remote patient monitoring, and meals, and this announcement has led to a 1.59% increase in the stock price of Modivcare's predecessor, DaVita.
	2023-03-15	-0.73 %
DaVita (DVA) stock is down -0.73% as part of a wider drop in US stocks due to fears of a banking crisis in Europe, begun by Credit Suisse's issues, and weak economic data.
	2023-03-14	+2.57 %
Davita (DVA) stock was up 2.57% last night; the article discusses the performance of Berkshire Hathaway, the holding company that owns a number of companies including Davita, Kraft Heinz, and Liberty Media, and how it has outperformed the S&P 500 by an almost unbelievable amount since 1965.
	2023-03-13	+0.51 %
DaVita's (DVA) stock went up by 0.51% after the announcement of its chief financial officer, Joel Ackerman's participation in a fireside chat with investors at the Barclays 2023 Global Healthcare Conference.
	2023-03-03	+1.3 %
The article is not about DaVita stock but rather the Dow Annual Report for 2022, in which the company highlighted their financial performance and their commitment to advancing sustainable and circular solutions which includes investments to reduce their emission by 30% by 2030 and to achieve carbon neutrality by 2050, and these efforts have likely contributed to the company's growth and success which has returned value to their shareholders.
	2023-02-28	-0.7 %
The stock price goes down because commentators are pessimistic about future performance and the company's high levels of debt.
	2023-02-27	+0.64 %
DaVita stock goes up because it is a valuable healthcare company that is expected to grow earnings in the future.
	2023-02-14	-1.02 %
Fresenius (FSNUF) plans to de-consolidate its subsidiary Fresenius Medical Care (FMS). While this may be a positive for shareholders as a deleverage play and as a rate the shares as a buy, there are many variables that could lower any positive impact. The largest negative event would be management stating that the deconsolidation of FMC is off the table.
	2023-02-08	-1.37 %
Davita's stock price goes down because it is a dialysis center operator, which is a recession-resistant industry.
	2023-02-03	-0.4 %
The pharmaceutical company Davita is having issues with its ACO REACH program.
	2023-02-01	+2.94 %
DaVita is a health care provider that is focused on transforming care delivery to improve the quality of life for patients globally. This has led to the company's stock price going up in the past.
	2023-01-18	+0.44 %
Pathalys Pharma, Inc., a private, late-stage biopharmaceutical company co-founded by Catalys Pacific and DaVita Venture Group, has raised $150 million through a combination of secured product financing and equity to support the two phase 3 clinical trials, registration efforts and pre-commercialization activities for upacicalcet.
	2023-01-17	+0.05 %
Some analysts believe that DaVita Inc. (NYSE:DVA) has a strong future, and investors are buying the stock based on this belief.
	2023-01-09	-2.89 %
institutional investors have a stake in the company so they might get excited when the stock prices go up but can also get too bullish and sell off the stock if prices fall
	2022-12-27	+0.19 %
fourth consecutive day of gains
	2022-11-02	-0.16 %
second consecutive day of losses
	2022-11-01	-4.3 %
the market wobbles and seems poised to head much lower
	2022-10-28	-27.09 %
lingering concerns about the COVID-19 pandemic Covid-19 and a labor shortage
	2022-10-18	+0.13 %
second consecutive day of gains